Selectins are adhesion receptors that participate in inflammation and tumor cell metastasis. The anti-inflammatory and antimetastatic activities of heparins have been related partly to their ability to interact with P-and L-selectin. The recent findings that various heparins differ in antimetastatic activity were explained by differences in their P-and L-selectin binding ability. To obtain data to illustrate the binding characteristics, we detected for the first time the binding kinetics and affinity of the two low molecular weight heparins (LMWHs) enoxaparin and nadroparin, and of the unfractionated heparin Liquemin N to P-and L-selectin using a quartz crystal microbalance biosensor. Enoxaparin and nadroparin behave nearly identical in their binding affinity to both P-selectin (K D 4.60 Â 10 À 6 M versus 7.61 Â 10 À 6 M) and L-selectin (K D 2.01 Â 10 À 6 M versus 2.84 Â 10 À 6 M). Liquemin N displayed slightly higher affinities to both selectins (K D 6.07 Â 10 À 7 M versus 1.07 Â 10 À 7 M). The differences are caused by a higher association rate compared with that of the LMWHs. These data support recent findings of antimetastatic activities, but illustrate that the intrinsic selectin binding does not entirely reflect the antimetastatic activities in vivo.
Three recent prospective clinical trials and a post hoc analysis of the CLOT (randomized comparison of LMWH versus oral anticoagulant therapy for the prevention of venous thromboembolism in patients with cancer) study suggest that low molecular weight heparins (LMWHs) prolong the survival in patients with advanced malignancy; in particular, patients with better prognosis benefit from LMWH therapy. [1] [2] [3] [4] [5] These clinical data are in line with the experimentally shown antimetastatic activity of heparins. 6, 7 However, there are still many unanswered questions, including those about the mechanism of the antimetastatic activity of heparins. Among the manifold biological effects of heparins, their ability to bind to both P-and L-selectin may contribute considerably to its anti-inflammatory and also antimetastatic activity. [8] [9] [10] [11] Selectins are carbohydrate-binding receptors involved in the leukocyte recruitment during the cellular immune response. 12 Although L-selectin is expressed constitutively on several types of leukocytes, P-selectin is stored in granula in endothelial cells and platelets, and rapidly mobilized to the surface upon various stimuli. 13 Tumor cells have been shown to express L-and P-selectin ligands that enable them to interact with the endothelium, platelets, and leukocytes during the metastatic process. [14] [15] [16] The involvement of selectins in metastasis could be confirmed in several animal experiments by the finding of reduced metastasis using selectin antibodies or selectin-deficient animals, respectively. [14] [15] [16] [17] In wild-type animals unfractionated heparin (UFH) also exhibited antimetastatic activity. However, in selectin-knockout mice, it did not further reduce metastasis formation. [16] [17] [18] [19] Therefore, P-and L-selectin appear to be the main molecular targets for heparin effects.
Given that there are considerable structural differences between UFH and LMWH, and also between the various LMWHs, the question arises whether they also differ in their antimetastatic activity. Two recent studies focused on a comparison of the inhibitory capacity of different heparins in experimental metastasis in mice. 20, 21 In both studies the synthetic pentasaccharide fondaparinux that corresponds to the antithrombinbinding site of heparin did not show an antimetastatic effect, nor did it bind to P-selectin. Given that the synthetic heparin derivative fondaparinux did not show any antimetastatic effect, an independence of antimetastatic effects from the anticoagulant activities was pointed out. Furthermore, deviations in the activities of heparins were reflected in functional assays on the inhibition of tumor cell binding. The different capacities were related to structural inhomogeneities and size fractionation.
Selectins are unique receptors with respect to their rapid bond formation. These peculiarities of the binding kinetics are also supposed to apply to selectinheparin interactions because both heparins and the physiological ligands are glucans. The aim of this study was to examine whether heparins with different selectinantagonizing capacities also display derivations in the binding kinetics to P-and L-selectin. For this purpose, we selected two LMWHs (enoxaparin and nadroparin) and the UFH Liquemin N (Hoffman-La-Roche AG, Grenzach-Wyhlen, Germany) that showed differences in antimetastatic activity in a recent study. 21 The quartz crystal microbalance (QCM) biosensor is a mass-sensitive transducer that is based on the piezoelectric properties of quartz crystals. An electrical excitation induces an oscillation of the quartz sensors. Given that the resonance frequency of these oscillations correlates with the mass load on its surface, 22 changes in mass can be detected in real time by monitoring of the frequency shifts.
We provide the first direct measurement of affinity and kinetics of fractionated heparins to both P-and L-selectin compared with UFH. The results confirm the impact of selectin-antagonizing action on antimetastatic activity insofar as the UFH with the highest activity displayed the strongest binding. The different antimetastatic activities of the two LMWHs did correlate with their functional inhibition of P-selectin, but not with their in vitro P-and L-selectin binding kinetics. This emphasizes the importance of several steps of the in vivo processing of heparins as factors affecting the activity.
EXPERIMENTAL PROCEDURES

Materials
Recombinant human P-selectin-Fc chimera and L-selectin-Fc chimera were purchased from R&D Systems (Wiesbaden, Germany). Purified mouse immunoglobulin G (IgG) 1-kappa was purchased from Becton Dickinson GmbH (Heidelberg, Germany). Bovine serum albumin (BSA) and cyanuric chloride were from Sigma (Deisenhofen, Germany). 6-Mercaptohexan-1-ol was purchased from Fluka (Neu-Ulm, Germany), and chloroform was from Riedel-de Haen (Seelze, Germany). All salts and buffers were of analytical grade. 
PREPARATION OF THE QUARTZ CRYSTAL SURFACE
Quartz crystals were cleaned using piranha solution (H 2 O 2 concentrate/H 2 SO 4 concentrate 1:3) and subsequently rinsed with demineralized water. This procedure was repeated three times. The quartz crystals were rinsed with ethanol (96% vol/vd) and dried under a stream of synthetic air. The cleaned quartz crystals were added to a 1 mM chloroform solution of 6-mercaptohexan-1-ol. After $12 hours at room temperature (RT), a thiolfunctionalized monolayer was formed. The quartz crystals were rinsed briefly with ethanol and dried under a stream of synthetic air. Then the quartz crystals were put into a chloroform solution of cyanuric chloride (1% mass/vd) for 2 hours at RT, again followed by ethanol washing and drying. The cyanuric chloride acted as a reactive linker onto the immobilized 6-mercaptohexan-1-ol for coupling the P-selectin-Fc chimera. A solution of 20 mL P-selectin-Fc-chimera in phosphate-buffered saline (PBS; 0.2 mg/mL) and 20 mL borate buffer (pH 8.8) was pipetted onto the upper gold surface of the quartz sensors. After 2 hours at RT, the quartz crystals were rinsed with demineralized water and dried under a stream of air. For blank experiments, a solution of 20 mL BSA (20% mass/vd) in water was used instead of the P-selectin-Fc chimera solution.
QCM MEASUREMENTS
QCM measurements were performed with a LiquiLab21 quartz crystal microbalance (ifak e.V., Barleben, Germany). Measurement chambers consist of polycarbonate and have a chamber volume of 100 mL. A peristaltic pump ensured the transport of the substance solutions to the quartz crystal surface under constant flow conditions. Quartz crystals with 10 MHz resonance frequency (14 mm diameter) were supplied by ifak e.V. The coated quartz crystals were inserted into the measurement chambers. PBS buffer with Ca 2 þ (1 mM) and Mg 2 þ (1 mM) was used for the flow. The experiments were performed under a flow rate of 270 mLÁmin -1 . This flow rate corresponds roughly to a shear rate of 5 second -1 . The quartz crystals were equilibrated under flow for 30 minutes leading to a constant resonance frequency. The indicated concentrations of UFH or LMWHs were added under constant flow conditions. The change of frequency was monitored in real time using the appropriate software.
CALCULATION OF THE KINETIC DATA
The kinetic data were calculated from the monitored frequency curves. The calculation required a first-order kinetic of the binding of the different heparins to L-and P-selectin. This was controlled by analyzing different concentrations of the compounds. A 1:1 binding of the compounds to the selectins was obtained in a low molar range. In this range of different concentrations the monitored frequency curves led to identical kinetic data. The lowest concentration of this range was selected for the experiments.
The association rate (on-rate, k on ) was calculated from the descending part of the curve according to Equation 1 . Df is the measured frequency change at the time t, [A] is the concentration of the injected heparin. f max is the maximum frequency change of the completely loaded quartz crystal. t 0 is the time when the decrease of the frequency begins.
After the maximum change of frequency is achieved, rinsing with PBS leads to a frequency increase. This increase permits the calculation of the dissociation rate (off-rate, k off ), according to Equation 2 , where f 0 is the frequency value at t 0 . t 0 is the point in time when the increase of frequency begins. f is the frequency value at the point in time t.
The k off /k on ratio yields the equilibrium dissociation constant K D (Equation 3 ).
Data are presented as means of at least three identical and independent experiments AE standard deviation.
RESULTS AND DISCUSSION
Application of the Biosensor System for Pand L-Selectin Binding Kinetics
The mass sensitivity of a QCM biosensor is based on the correlation between the mass loaded on the sensor surface, induced by biological binding processes, and the changes in the resonance frequency of the sensor. To obtain specific binding and recognition processes, the biofunctionalization of the sensor surface is an essential prerequisite. Therefore, we immobilized P-selectinFc-chimera or L-selectin-Fc-chimera chemically on the surface. According to validation experiments, 4 mg of each selectin was considered optimal with respect to the selectin amount/binding ratio. The accessibility of immobilized selectins was confirmed using selectin antibodies, which displayed strong and significant binding compared with nonspecific IgG (data not shown).
The binding of compounds from the flow medium onto the selectin-functionalized quartz surface can be observed in real time following the frequency shifts, as illustrated in Fig. 1 .
After the resonance frequency was equilibrated under flow of pure medium, medium containing the test compound was injected into the system. Binding of the compound led to a decrease in frequency to a minimum that represents the equilibrium of binding. Replacement of the compound solution by pure medium led to the dissociation of bound compounds. The dissociation is reflected in a certain frequency increase and the course of frequency changes allows the calculation of the kinetic binding constants according to Equations 1 to 3.
Binding Kinetics of UFH to P-and L-Selectin
Liquemin N was shown to possess a significant Pselectin-antagonizing capacity in our previous in vitro studies on the inhibition of cell rolling. 23 No experimental data exist for this UFH with respect to L-selectin binding. Other UFHs have been described to generally bind to L-selectin. Although different UFH preparations may vary in their structural composition and in their biological activities, 24 binding of Liquemin N to L-selectin could be anticipated.
To apply the established QCM system for the detection of binding kinetics of Liquemin N to P-and L-selectin, we first evaluated the optimal heparin concentration. In the clinical application as antithrombotics, UFH is dosed in International Units (IU), reflecting their respective in vitro anticoagulant activity. Although it was shown that the anticoagulant activity is not correlated with other biological activities, such as selectin inhibition, heparin was either used on mass basis or according to International Units for several selectin studies. 16, 18, 20, [23] [24] [25] QCM is a mass-sensitive technique and therefore exact gravimetric comparisons should be maintained. However, detection of binding kinetic has the obvious advantage of being independent of concentrations, as long as a 1:1 binding stoichiometry according to the Langmuir absorption model is assured. We analyzed the kinetic binding behavior of different concentrations ranging from 1.28 Â 10 À 6 M (17 mg/mL) to 1.28 Â 10 À 5 M (170 mg/mL) considering the indicated average MW for calculating the molar concentrations. All UFH concentrations within this range displayed similar k off values. Higher amounts than $67 mg/mL tended to lower the k on . The lower k on values indicate that not all of the heparin molecules bind to the immobilized selectins adequately. In this case, Equation 1 cannot be applied properly to calculate k on .
Therefore, we used a concentration of 2.56 Â 10 À 6 M (33 mg/mL) Liquemin N for the P-and L-selectin binding experiments. The obtained kinetic binding data are summarized in Table 1 .
The K D values of 6.07 Â 10 À 7 M and 1.06 Â 10 À 7 M, respectively, illustrate that Liquemin N binds with high affinity to both P-and L-selectin. These data confirm numerous approaches to use heparin as a selectin inhibitor in inflammation and tumor metastasis. 26, 27 The affinity of Liquemin N to L-selectin is even higher than that to P-selectin, and results from both a faster association (on-rate) and a slower dissociation (offrate). Considering the differences in binding kinetics of P-and L-selectin toward their respective physiological ligands, one could not have anticipated these findings. 28, 29 However, the P-selectin affinity of Liquemin N is consistent with the data recently presented by Wang et al, 30 the only published data of heparin-selectin binding kinetics. The authors analyzed the interaction of soluble P-selectin with BSA-conjugated heparin, immobilized on the chip sensor surface of a surface plasmon resonance. The off-rate of $3.15 Â 10 À 3
Ásecond
-1 described by Wang et al is close to our findings. The 10-fold higher on-rate might be explained by differences in the experimental setup (i.e., the immobilization of heparin as described by Wang et al 30 versus the use of immobilized selectin in our approach). The resulting affinity of 1.15 Â 10 À 7 M is lower than our findings (6.07 Â 10
M) due to the differences in the on-rate. Nevertheless, both the data of Wang et al 30 and our data demonstrate that UFH binds with strong affinity in the high nanomolar range to both P-and L-selectin. The potential as selectin inhibitor results from the much slower off-rate compared with the physiological ligands.
P-and L-Selectin Binding Kinetics of Two Different LMWHs
Each of the clinically applied LMWHs is produced by its own procedure. This leads to certain differences in their respective structural composition that may have implications for their activity profile. 31 Various LMWHs have been investigated in several selectin-related experiments, but data on binding affinity that would allow a real comparison between the selectin binding potencies of UFH and the class of LMWHs and between those of different LMWHs do not exist. We selected enoxaparin and nadroparin for our binding studies. In a recent study, enoxaparin was found to be less active than tinzaparin and dalteparin in binding L-selectin. In binding Pselectin, it was less active than tinzaparin as well, but Table 1 Kinetic Constants of Liquemin N Binding to Immobilized P-Selectin and L-Selectin, Calculated from the Frequency Slopes of the QCM Measurements (means AE SD; n ! 3) QCM, quartz crystal microbalance; SD, standard deviation; K D , equilibrium dissociation constant; k on , association rate; k off , dissociation rate.
ABILITY OF HEPARINS TO BIND WITH P-AND L-SELECTIN/SIMONIS ET AL
as active as dalteparin. 20 Furthermore, enoxaparin was reported to be inferior to nadroparin in both binding Pselectin and reducing the experimental lung metastasis of melanoma cells in mice. 21 To apply the QCM technique for the LMWH detection, we first optimized the concentration of the compound needed for the binding detection. A concentration of 100 mg/mL was considered optimal. This appears sensible with respect to the MW and to the used concentration of Liquemin N. The binding kinetic data of both LMWHs to P-and L-selectin are summarized in Table 2 .
It is evident that both LMWHs display nearly identical binding characteristics. As already detected for Liquemin N, the LMWHs bind slightly better to L-selectin than to P-selectin. The affinity increase is driven mainly by a slower off-rate from L-selectin than from P-selectin. The general binding affinity of both LMWHs is lower compared with UFH. The reason is expressed markedly in the approximately 5-fold slower on-rates of the LMWHs. This might be explained by the slightly lower charge density of LMWHs and/or their lower chain length compared with UFH. Both factors result in a lower total number of negative charges per molecule as potential contact points to P-selectin. Moreover, this is in line with our previous finding that charge density is the dominant factor for selectin binding. 23 In summary, the data illustrate that the two LMWHs used in this study represent equally active potent P-and L-selectin inhibitors, and that slight binding differences compared with UFH can be explained by structural parameters.
CONCLUSIONS
This study provides for the first time kinetic binding constants and affinity data of two LMWHs and one UFH to both P-and L-selectin. The data confirm that all three heparins represent potent inhibitors that are active in a low micromolar or high nanomolar range, respectively. The similar P-and L-selectin binding characteristics of each of the heparins demonstrate that the two receptors have identical structural requirements to those of their inhibitors. The data emphasize the importance of considering the binding kinetics, given that the slightly increased affinity of UFH compared with LMWH can be explained clearly by a higher association tendency toward the receptors. The higher binding affinity of UFH versus LMWH is reflected in various cell binding assays, and LMWHs with higher MW and charge density, such as tinzaparin, were shown to increase the selectin binding ability. 20 The two recent studies comparing the antimetastatic activities of different heparins found that UFH slightly exceeded the effects of the selected LMWHs. 20, 21 Our data confirm these findings and emphasize the role of selectin inhibition for reducing cancer cell metastasis. However, the intrinsic binding ability of different LMWHs in vitro does not necessarily correlate with the antimetastatic activity. The in vivo effects obviously are influenced by several additional factors, such as pharmacodynamics or biodistribution, which might result from structural differences other than MW and charge density between them. This could explain why we found absolute identical affinities of nadroparin and enoxaparin to P-and L-selectin, although both products displayed differences in the recent antimetastatic experiments. 21 To conclude, several heparins represent very potent inhibitors of both P-and L-selectin. This characteristic is influenced strongly by structural parameters and results clearly from beneficial binding kinetics, such as much slower off-rates compared with the physiological ligands. These findings emphasize the hypothesis that the antimetastatic activity of heparins is based dominantly on inhibition of P-and L-selectin. However, the selectin binding kinetics cannot be correlated directly with antimetastatic activity in all cases. Obviously, structural differences between distinct heparin preparations may have no influence on a single pharmacodynamic effect, but may have implications for the overall in vivo effects as the result of a very complex process.
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